Combination treatment of rituximab and donor platelets infusion to reduce donor‐specific anti‐HLA antibodies for stem cells engraftment in haploidentical transplantation

BACKGROUND: Donor‐specific anti‐human leukocyte antigen (HLA) antibodies (DSAs) in recipients is a risk factor for donor stem cell graft failure in haploidentical hematopoietic stem cell transplantation (haplo‐HSCT), and the treatment to reduce the levels of DSAs is not unanimous. This study was to...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Clin Lab Anal
Egile Nagusiak: Zhang, Rongli, He, Yi, Yang, Donglin, Jiang, Erlie, Ma, Qiaoling, Pang, Aiming, Zhai, Weihua, Wei, Jialin, Feng, Sizhou, Han, Mingzhe
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2020
Gaiak:
Research Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7370703/
https://ncbi.nlm.nih.gov/pubmed/32112480
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcla.23261
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak